Skip to main content

Table 3 The best overall response (overall response rate)

From: Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasis

Group

Response

CR

PR

NC

PD

Total

GEF

RT( +)

23 (59%)

16 (41%)

0

0

39

RT(‐)

5 (31%)

10 (63%)

1 (6%)

0

16

total

28 (51%)

26 (47%)

1 (2%)

0

55

Control

RT( +)

3 (10%)

21 (68%)

6 (19%)

1 (3%)

31

RT(‐)

0

6 (27%)

4 (18%)

12 (55%)

22

total

3 (6%)

27 (51%)

10 (19%)

13 (25%)

53